VIGILI de KREUTZENBERG, SAULA
VIGILI de KREUTZENBERG, SAULA
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus
2024 Mantovani, Alessandro; Morieri, Mario Luca; Aldigeri, Raffaella; Palmisano, Luisa; Masulli, Maria; Bonomo, Katia; Baroni, Marco Giorgio; Cossu, Efisio; Cimini, Flavia Agata; Cavallo, Gisella; Buzzetti, Raffaella; Mignogna, Carmen; Leonetti, Frida; Bacci, Simonetta; Trevisan, Roberto; Pollis, Riccardo Maria; Cas, Alessandra Dei; de Kreutzenberg, Saula Vigili; Targher, Giovanni
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus
2023 Csermely, Alessandro; Mantovani, Alessandro; Morieri, Mario Luca; Palmisano, Luisa; Masulli, Maria; Cossu, Efisio; Baroni, Marco Giorgio; Bonomo, Katia; Cimini, Flavia Agata; Cavallo, Gisella; Buzzetti, Raffaella; Mignogna, Carmen; Leonetti, Frida; Bacci, Simonetta; Trevisan, Roberto; Pollis, Riccardo Maria; Aldigeri, Raffaella; Cas, Alessandra Dei; de Kreutzenberg, Saula Vigili; Targher, Giovanni
Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes
2023 Giannella, Alessandra; Castelblanco, Esmeralda; Zambon, Carlo Federico; Basso, Daniela; Hernandez, Marta; Ortega, Emilio; Alonso, Nuria; Mauricio, Didac; Avogaro, Angelo; Ceolotto, Giulio; Vigili de Kreutzenberg, Saula
Commentary on: "HOMA-IR as a Predictor of Health Outcomes in Patients with Metabolic Risk Factors: A Systematic Review and Meta-Analysis" by González-González JG et al. High Blood Pressure & Cardiovascular Prevention
2023 Vigili de Kreutzenberg, S
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus
2023 Mantovani, Alessandro; Morieri, Mario Luca; Palmisano, Luisa; Masulli, Maria; Cossu, Efisio; Baroni, Marco Giorgio; Bonomo, Katia; Cimini, Flavia Agata; Cavallo, Gisella; Buzzetti, Raffaella; Mignogna, Carmen; Leonetti, Frida; Bacci, Simonetta; Trevisan, Roberto; Pollis, Riccardo Maria; Aldigeri, Raffaella; Cas, Alessandra Dei; de Kreutzenberg, Saula Vigili; Targher, Giovanni
Sex differences in cardiovascular disease and cardiovascular risk estimation in patients with type 1 diabetes
2023 Dei Cas, A; Aldigeri, R; Mantovani, A; Masulli, M; Palmisano, L; Cavalot, F; Bonomo, K; Baroni, Mg; Cossu, E; Cavallo, G; Cimini, Fa; Buzzetti, R; Mignogna, C; Leonetti, F; Bacci, S; Trevisan, R; Morieri, Ml; Pollis, Rm; Targher, G; Vigili de Kreutzenberg, S.
A miR-125/Sirtuin-7 pathway drives the pro-calcific potential of myeloid cells in diabetic vascular disease
2022 Vigili de Kreutzenberg, Saula; Giannella, Alessandra; Ceolotto, Giulio; Faggin, Elisabetta; Cappellari, Roberta; Mazzucato, Marta; Fraccaro, Chiara; Tarantini, Giuseppe; Avogaro, Angelo; Fadini, Gian Paolo
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history
2022 Avogaro, Angelo; de Kreutzenberg, Saula Vigili; Morieri, Mario Luca; Fadini, Gian Paolo; Del Prato, Stefano
Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience
2022 de Kreutzenberg, Saula Vigili
The effect of GLP-1 receptor agonists on N-terminal pro-brain natriuretic peptide. A scoping review and metanalysis
2022 Avogaro, A.; Azzolina, D.; Gregori, D.; De Kreutzenberg, S.; Fadini, G. P.; Mannucci, E.
[Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Italy]
2021 Battistoni, Allegra; Gallo, Giovanna; Aragona, Caterina Oriana; Barchiesi, Fabio; Basolo, Alessio; Bellone, Simonetta; Bellotti, Paolo; Bertolotti, Marco; Bianco, Andrea; Biffi, Alessandro; Borghi, Claudio; Cicero, Arrigo Francesco Giuseppe; Consoli, Agostino; Corsini, Alberto; Desideri, Giovambattista; Di Giacinto, Barbara; Fernando, Fredrik; Ferri, Claudio; Galiuto, Leonarda; Grassi, Davide; Grassi, Guido; Icardi, Giancarlo; Indolfi, Ciro; Lodi, Elisa; Modena, Maria Grazia; Muiesan, Maria Lorenza; Nati, Giulio; Orsi, Andrea; Palermi, Stefano; Parati, Gianfranco; Passantino, Andrea; Patelli, Alessandra; Pelliccia, Antonio; Pengo, Martino; Filardi, Pasquale Perrone; Perseghin, Gianluca; Pirro, Matteo; Pontremoli, Roberto; Rengo, Giuseppe; Ricotti, Roberta; Rizzoni, Damiano; Rocca, Bianca; Rotella, Carlo; Rubattu, Speranza; Salvetti, Guido; Sciacqua, Angela; Serdoz, Andrea; Sirico, Felice; Squeo, Maria Rosaria; Tocci, Giuliano; Trimarco, Bruno; Vigili de Kreutzenberg, Saula; Volpe, Roberto; Volpe, Massimo
Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes
2021 Morieri, M. L.; Perrone, V.; Veronesi, C.; Degli Esposti, L.; Andretta, M.; Plebani, M.; Fadini, G. P.; Vigili de Kreutzenberg, S.; Avogaro, A.
PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes.
2021 Giannella, Alessandra; Ceolotto, Giulio; Radu, CLAUDIA-MARIA; Cattelan, Arianna; Iori, Elisabetta; Benetti, Andrea; Fabris, Fabrizio; Simioni, Paolo; Avogaro, Angelo; VIGILI de KREUTZENBERG, Saula
Where diabetes care meets cardiovascular research: our cardiovascular perspective at a Centre devoted to diabetes research and care
2021 Fadini, Gian Paolo; Vigili de Kreutzenberg, Saula; Avogaro, Angelo
Effects of Basal Insulin on Lipid Profile Compared to Other Classes of Antihyperglycemic Agents in Type 2 Diabetic Patients
2020 Rigato, Mauro; Avogaro, Angelo; Vigili de Kreutzenberg, Saula; Fadini, Gian Paolo
Prevalence of orthorexic traits in type 2 diabetes mellitus: at the crossroads between nutritional counseling and eating disorders.
2020 Barbanti, Fa; Trento, M; Bruno, G; Bonadonna, R; Croci, M; D'Eusebio, C; Dei Cas, A; Invitti, C; Merlo, F; Pontiroli, Ae; Veronelli, A; Vigili de Kreutzenberg, S; Marchesini, G; Petroni, Ml.
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention.
2020 Volpe M, Battistoni A; board of the Italian Society of Cardiovascular, Prevention; Bellotti, P; Bellone, S; Bertolotti, M; Biffi, A; Consoli, A; Corsini, A; Desideri, G; Ferri, C; Modena, Mg; Nati, G; Pirro, M; Rubattu, S; Tocci, G; Trimarco, B; Volpe, R; de Kreutzenberg, Sv.
Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations
2019 Petroni, M. L.; Barbanti, F. A.; Bonadonna, R.; Bruno, G.; Caletti, M. T.; Croci, M.; D'Eusebio, C.; Dei Cas, A.; Invitti, C.; Merlo, F.; Molteni, A.; Pontiroli, A.; Trento, M.; Veronelli, A.; Vigili de Kreutzenberg, S.; Marchesini, G.
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial
2019 Bonora, B. M.; Vigili De Kreutzenberg, S.; Avogaro, A.; Fadini, G. P.
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study
2019 Morieri, M. L.; Longato, E.; Mazzucato, M.; Di Camillo, B.; Cocchiglia, Arianna; Gubian, L.; Sparacino, G.; Avogaro, A.; Fadini, G. P.; Vigili de Kreutzenberg, S.